How Much Revenues Does Roche Stand To Lose Given The FDA Nod For Pfizer's Biosimilar For Avastin?Forbes • 07/05/19
Why This Gene Therapy Stock Looks Like A Sure Takeover Bet: AnalystInvestors Business Daily • 06/17/19
Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug FailuresInvestors Business Daily • 06/14/19
Roche Extends Deadline For Spark Acquisition As US, UK Regulators Seek Additional InformationBenzinga • 06/10/19
FDA approves Genentech's Polivy as part of first chemoimmunotherapy regimen for patients with diffuse large B-cell lymphomaMarket Watch • 06/10/19
Roche's $4.8 Billion Buyout Of Spark Delayed Amid Competitive WorriesInvestors Business Daily • 06/10/19
Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster HeadacheZacks Investment Research • 06/07/19